News
18hon MSN
A recent phase 2 clinical trial reveals that Ambroxol, a common cough medicine, shows promise in stabilizing psychiatric ...
2d
ScienceAlert on MSNCough Medicine May Protect Against Some of Parkinson's Worst SymptomsAn active ingredient in cough medicines since 1979 has shown promise as a treatment for neuropsychiatric symptoms in ...
Researchers at the Lawson Health Research Institute, part of St. Joseph’s Health Care London, are studying Ambroxol, a cough ...
Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...
A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly ...
Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...
A COMMON cough medicine could help protect against dementia. A study found that it prevented people with Parkinson’s develop ...
A landmark study by London researchers investigating the use of a cough medicine called Ambroxo to slow the progression of ...
Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...
A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people ...
A common cough syrup, Ambroxol, has shown potential in slowing the progression of Parkinson's dementia in a recent clinical trial.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results